Congress Wealth Management LLC DE trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 129,051 shares of the specialty pharmaceutical company’s stock after selling 30,095 shares during the quarter. Congress […]